Jiang Yio, MD, MBA
Advertisement
Articles by Jiang Yio, MD, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Onc
1
FDA Approves Amivantamab and Hyaluronidase for Recurrent/Metastatic HNSCC
2
How Will Pancreatic, Prostate, and Endometrial Cancer Care Change by 2031?
3
Zanubrutinib Plus Rituximab Receives FDA Priority Review in Frontline MCL
4
A New Era in Sarcoma Treatment? Dr Banks on the Potential of TIL Therapy
5
